Rating History for Neurocrine Bio. (NBIX) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for NBIX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/5/2026 Delma Caiati New Coverage Buy
(N/A)		 207.00
(N/A)		 143.18
(145.87)		 1.88% Details